دورية أكاديمية
Combination therapy for visceral leishmaniasis.
| العنوان: | Combination therapy for visceral leishmaniasis. |
|---|---|
| المؤلفون: | van Griensven J; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium. jvangriensven@itg.be, Boelaert M |
| المصدر: | Lancet (London, England) [Lancet] 2011 Feb 05; Vol. 377 (9764), pp. 443-4. Date of Electronic Publication: 2011 Jan 20. |
| نوع المنشور: | Comment; Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2004- : London : Elsevier Original Publication: London : J. Onwhyn |
| مواضيع طبية MeSH: | Amphotericin B/*administration & dosage , Antiprotozoal Agents/*administration & dosage , Leishmaniasis, Visceral/*drug therapy , Paromomycin/*administration & dosage , Phosphorylcholine/*analogs & derivatives, Amphotericin B/adverse effects ; Antiprotozoal Agents/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Humans ; India ; Paromomycin/adverse effects ; Phosphorylcholine/administration & dosage ; Phosphorylcholine/adverse effects ; Randomized Controlled Trials as Topic |
| التعليقات: | Comment on: Lancet. 2011 Feb 5;377(9764):477-86. (PMID: 21255828) |
| المشرفين على المادة: | 0 (Antiprotozoal Agents) 0 (liposomal amphotericin B) 107-73-3 (Phosphorylcholine) 53EY29W7EC (miltefosine) 61JJC8N5ZK (Paromomycin) 7XU7A7DROE (Amphotericin B) |
| تواريخ الأحداث: | Date Created: 20110125 Date Completed: 20110317 Latest Revision: 20150616 |
| رمز التحديث: | 20240513 |
| DOI: | 10.1016/S0140-6736(10)62237-4 |
| PMID: | 21255829 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1474-547X |
|---|---|
| DOI: | 10.1016/S0140-6736(10)62237-4 |